Asymmetry Capital Management, L.P., an alternative asset management firm launched in 2013 by Scott Kay, is pleased to announce that Alex Virgilio, Ph.D. has joined the Asymmetry Investment Team as an Analyst and Partner covering global biotech and therapeutics, based in the firm’s San Francisco headquarters
August 22, 2019
· 2 min read